Global Fluorescent in Situ Hybridization (FISH) Market - Industry Trends and Forecast to 2030
The global Fluorescent in Situ Hybridization (FISH) market is projected to register a CAGR of 8.2% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Market SegmentationGlobal Fluorescent in Situ Hybridization (FISH) Market, By Product Type (Consumables, Instrument, and Software), Technology (DNA Fluorescent in Situ Hybridization, RNA Fluorescent in Situ Hybridization, PNA Fluorescent in Situ Hybridization, and Others), Application (Cancer Research, Genetic Research, Infectious Disease, Personalized Medicine, and Other), Usage (Clinical, Research, and Companion Diagnostic), End User (Hospitals & Clinics, Diagnostic Laboratories, Pharmaceuticals & Biotechnology Companies, Contract Research Organizations, Academic & Research Institutes, and Others), Distribution Channel (Retail Sales, Direct Tender, Online Sales, and Others), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Russia, Spain, Netherlands, Switzerland, Norway, Poland, Sweden, Belgium, Turkey, Denmark, Finland, Rest of Europe, China, Japan, India, Australia, New Zealand, South Korea, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Taiwan, Rest of Asia-Pacific, South Africa, Saudi Arabia, Bahrain, UAE, Kuwait, Oman, Qatar, Egypt, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America) - Industry Trends and Forecast to 2030
Some of the major factors contributing to the growth of the global Fluorescent in Situ Hybridization (FISH) market are:• Growing demand for better quality healthcare for genetic disorders and the rising adoption of personalized medicine
• Increasing use of the FISH technique due to the rise in patients with breast cancer and other chronic diseases
Market PlayersSome of the major market players operating in the global Fluorescent in Situ Hybridization (FISH) market are:• Abbott
• Abcam plc.
• Abnova Corporation
• Agilent Technologies, Inc.
• Bio SB
• Biocare Medical, LLC
• BioCat GmbH
• BioDot
• BioGenex
• Bio-Techne
• BIOZOL Diagnostics Vertrieb GmbH
• Excilone
• F.Hoffmann-La Roche Ltd
• Genemed Biotechnologies, Inc.
• Kaneka Eurogentec S.A.
• Leica Biosystems Nussloch GmbH
• Merck KGaA
• MetaSystems
• Sysmex Asia-Pacific Pte Ltd (a subsidiary of Sysmex Corporation)
• Thermo Fischer Scientific Inc.
• Zytomed Systems GmbH
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.
Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.